Skip to content
Search

Latest Stories

Obesity increases risks of death from Covid-19

People who are obese or overweight are at increased risk of death or severe illness from Covid-19, a report by Public Health England (PHE) said on Saturday (July 25) as the government prepares to introduce measures to confront the problem.

Prime minister Boris Johnson has pledged to tackle obesity and has himself lost weight since he was admitted to intensive care with Covid-19.


PHE said data showed that for people with a Body Mass Index (BMI) of 30-35, risk of death from Covid-19 increased by 40 per cent, and it increased by 90 per cent for those with a BMI over 40 compared to those of a healthy weight.

People with a BMI of over 30 are classed as obese under the system. PHE said that almost 63 per cent of adults in England are overweight or obese.

"The current evidence is clear that being overweight or obese puts you at greater risk of serious illness or death from Covid-19, as well as from many other life-threatening diseases," said Alison Tedstone, chief nutritionist at PHE.

On Friday, Johnson said people should lose weight, with reports that government restrictions on advertising unhealthy foods could come next week.

"I'm not normally a believer in nannying, bossing politics but the reality is that obesity is one of the comorbidity factors," Johnson said.

Susan Jebb, Professor of Diet and Population Health at the University of Oxford, said she would be pleased to see Johnson acknowledge the extent of the public health crisis Britain faces when it comes to tackling obesity.

"That's been brought to the fore by Covid, but actually it's something that we've kind of known all along, but it's just never got to the top of government's to-do list," Jebb, who reviewed the PHE report, told reporters.

(Reuters)

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less